Franklin Resources Inc Logic Bio Therapeutics, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.35 - $0.74 $214,751 - $454,046	-613,576 Reduced 67.16%	300,000 $109,000
Q1 2022 May 13, 2022	SELL	$0.61 - $2.49 $417,922 - $1.71 Million	-685,119 Reduced 42.85%	913,576 $621,000
Q4 2021 Feb 11, 2022	BUY	$2.2 - $4.53 $112 - $231	51 Added 0.0%	1,598,695 $3.69 Million
Q4 2020 Feb 10, 2021	BUY	$5.29 - $9.1 $4.75 Million - $8.18 Million	898,644 Added 128.38%	1,598,644 $12.2 Million
Q4 2018 Feb 12, 2019	BUY	$7.88 - $17.98 $5.52 Million - $12.6 Million	700,000 New	700,000 $7.28 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.